APA (7th ed.) Citation

Ding Wang, Kailibinuer Keyoumu, Rongji Yu, Doudou Wen, Hao Jiang, Xinchun Liu, . . . Shubing Zhang. (2024). Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway. BMC.

Chicago Style (17th ed.) Citation

Ding Wang, Kailibinuer Keyoumu, Rongji Yu, Doudou Wen, Hao Jiang, Xinchun Liu, Xiaotang Di, and Shubing Zhang. Extracellular Matrix Marker LAMC2 Targets ZEB1 to Promote TNBC Malignancy via Up-regulating CD44/STAT3 Signaling Pathway. BMC, 2024.

MLA (9th ed.) Citation

Ding Wang, et al. Extracellular Matrix Marker LAMC2 Targets ZEB1 to Promote TNBC Malignancy via Up-regulating CD44/STAT3 Signaling Pathway. BMC, 2024.